Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
|
|
TETRAPHASE PHARMACEUTICALS INC (TTPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/31/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 08/31/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/31/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/31/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/24/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/24/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/24/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/24/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/30/2020 |
4
| ARMISTICE CAPITAL, LLC (10% Owner) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Disposed of 1,419,507 shares
@ $0
Disposed of 1,430,493 options to buy
@ $0.01, valued at
$14.3k
Disposed of options to buy
@ $0.01, valued at
$0
Disposed of 2,063,334 options to buy
@ $0.001, valued at
$2.1k
Disposed of options to buy
@ $0.001, valued at
$0
Disposed of 2,130,493 warrants
@ $3.62, valued at
$7.7M
Disposed of warrants
@ $3.62, valued at
$0
Disposed of 3,333,334 warrants
@ $2.87, valued at
$9.6M
Disposed of warrants
@ $2.87, valued at
$0 |
|
| 07/30/2020 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Tetraphase Pharmaceuticals, Inc. |
| 07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
4
| Macdonald Guy (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 15,703 shares
@ $0 |
|
| 07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
8-K
| Quarterly results |
| 07/28/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 07/28/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 07/28/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/28/2020 |
GN
| La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc. |
|
|
|